SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 5th, 2018 • Medizone International Inc • Wholesale-drugs, proprietaries & druggists' sundries • Kansas
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 31, 2018, by and between MEDIZONE INTERNATIONAL, INC., a Nevada corporation, with headquarters located at 350 East Michigan Avenue, Suite 500, Kalamazoo, Michigan 49007 (the “Company”), and L2 CAPITAL, LLC, a Kansas limited liability company, with its address at 8900 State Line Rd., Suite 410, Leawood, KS 66206 (the “Buyer”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 5th, 2018 • Medizone International Inc • Wholesale-drugs, proprietaries & druggists' sundries • Kansas
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of January 31, 2018, by and between MEDIZONE INTERNATIONAL, INC., a Nevada corporation (the "Company"), L2 CAPITAL, LLC, a Kansas limited liability company (“L2”), and SBI INVESTMENTS LLC, 2014-1, a statutory series of Delaware limited liability company (“SBI”) (together with their respective permitted assigns, L2 and SBI shall collectively be referred to herein as the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Equity Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
COMMON STOCK PURCHASE WARRANT MEDIZONE INTERNATIONAL, INC.Medizone International Inc • February 5th, 2018 • Wholesale-drugs, proprietaries & druggists' sundries • Kansas
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the $152,500.00 convertible promissory note to the Holder (as defined below) of even date) (the “Note”), SBI Investments LLC, 2014-1, a statutory series of Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Medizone International, Inc., a Nevada corporation (the “Company”), up to 2,833,168 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated Januar
EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • February 5th, 2018 • Medizone International Inc • Wholesale-drugs, proprietaries & druggists' sundries • Kansas
This EQUITY PURCHASE AGREEMENT is entered into as of January 31, 2018 (this "Agreement"), by and among Medizone International, Inc., a Nevada corporation (the "Company"), L2 Capital, LLC, a Kansas limited liability company (“L2”), and SBI Investments LLC, 2014-1, a statutory series of Delaware limited liability company (“SBI”) (together with it permitted assigns, L2 and SBI shall collectively be referred to herein as the "Investor" or “Participating Investors”).
TRADING AGREEMENTTrading Agreement • February 5th, 2018 • Medizone International Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
This Trading Agreement (this “Agreement”), dated as of the 31st day of January, 2018 (the “Effective Date”), is entered into by and between L2 Capital, LLC (“L2”) and SBI Investments LLC, 2014-1 (“SBI,” and together with L2, the “Parties” and each, a “Party”).
